- Home
- TMUS vs LLY Comparison
TMUS vs LLY Comparison
Compare TMUS & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMUS | LLY |
|---|---|---|
| Founded | 1994 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.5B | 994.5B |
| IPO Year | 2004 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TMUS | LLY |
|---|---|---|
| Price | $147.50 | $1,269.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 31 |
| Target Price | $236.84 | ★ $1,328.05 |
| AVG Volume (30 Days) | ★ 5.2M | 1.9M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.95% | 0.53% |
| EPS Growth | 0.62 | ★ 95.99 |
| EPS | 5.26 | ★ 16.19 |
| Revenue | $40,604,000,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $6.82 | $35.86 |
| Revenue Next Year | $4.43 | $15.53 |
| P/E Ratio | ★ $30.17 | $80.65 |
| Revenue Growth | 9.03 | ★ 44.70 |
| 52 Week Low | $148.12 | $809.63 |
| 52 Week High | $224.75 | $1,321.21 |
Technical Indicators
Market Signals| Indicator | TMUS | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 60.91 |
| Support Level | N/A | $1,113.45 |
| Resistance Level | $189.08 | $1,292.65 |
| Average True Range (ATR) | 4.75 | 36.38 |
| MACD | -0.15 | 10.82 |
| Stochastic Oscillator | 2.42 | 72.61 |
Price Performance
Historical ComparisonAbout TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves about 86 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 8 million residential and business customers with its wireless network. It also serves 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.